Clifford Perlis, MD
Procedural Dermatology · Philadelphia, PANPI 1548251481
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $249 of the $349 with a category attached, or 71.3%. 6 manufacturers reported payments, led by Kerecis Limited at 35.6% of the total. Reporting peaked in 2024 at $283 and has fallen 82.1% since, to $51 in 2025. That places this record below the midpoint for procedural dermatology clinicians in PA, where the typical reported total is $349.
Across 9 payments — averaging $38.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$124
- Sun Pharmaceutical Industries Inc.$100
- LEO Pharma Inc.$58
- AbbVie$30
- Arcutis Biotherapeutics, Inc.$22
- Merck$15
What the payments were for
- Food & beverage$24971%
- Education$10029%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 2 | $124 |
| Sun Pharmaceutical Industries Inc. | 1 | $100 |
| LEO Pharma Inc. | 2 | $58 |
| AbbVie | 2 | $30 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| Merck | 1 | $15 |
How this compares
$349 in reported general payments places this provider in the 50th percentile of 26 procedural dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 20 | $135,174 |
| Dupixent PenDupilumab | 13 | $50,974 |
| Fluorouracil | 41 | $2,545 |
| Tacrolimus | 24 | $1,851 |
| Clobetasol Propionate | 30 | $1,488 |
| Cefdinir | 74 | $1,111 |
| Ketoconazole | 51 | $939 |
| Triamcinolone Acetonide | 73 | $866 |
| Cephalexin | 100 | $768 |
| Mometasone Furoate | 19 | $282 |
| Hydrocortisone | 27 | $167 |
| Doxycycline Hyclate | 23 | $165 |
| Clindamycin Hcl | 22 | $74 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $40 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Philadelphia
- Barbara MathesPhiladelphia$7K
- Anne AngelesPhiladelphia$2K
- Louis BrownPhiladelphia$1K
- Steven GreenbaumPhiladelphia$198
- Jonathan WolfePlymouth Meeting$252K
- Stuart GlasserGreensburg$13K
- Danielle DehoratiusBryn Mawr$12K
- Anthony SantoroDoylestown$8K
- Vincent HerbstWilliamsport$4K
- Elizabeth AndersonCamp Hill$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.